Abraxane Safety Questions, Abraxane Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides information about Abraxane side effects. Check out Health Surveys and Health Polls. If you have questions about Abraxane, you can post them to our Doctors or Ask Patient Community about Abraxane.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Help Community - Post Your Side Effect
Ask Our Doctors about Abraxane
Abraxane Safety Reports
Total Abraxane reports: 101.Abraxane FDA safety alerts: No.
Reported deaths: 15 Reported hospitalizations: 60.
Take Abraxane Side Effects Survey or Share Your Abraxane Story.
Reported Abraxane Side Effects: facial palsy, dehydration, neuropathy peripheral, nausea, pneumonia, pain in extremity, mucosal inflammation, pleural effusion, vomiting, haemoglobin decreased, oedema peripheral.
Abraxane Usage.
Showing 1-50 of 101 Next >
Abraxane Side Effects Report #5080800-8Consumer or non-health professional from UNITED STATES reported ABRAXANE problem on July 25, 2006. Female patient, 51 years of age, was diagnosed with breast cancer metastatic and was treated with ABRAXANE. After drug was administered, patient experienced the following problems/side effects: cranial neuropathy, facial nerve disorder, facial palsy, neurotoxicity. ABRAXANE dosage: 149MG LAST DOSE; FIRST DOSE 150 MG (SCHEDULED FOR EVERY WEEK) INTRAVENOUS DRIP. During the same period patient was treated with VINORELBINE, HERCEPTIN, VITAMIN, RANITIDINE. Patient recovered.
Abraxane Side Effects Report #5081333-5
ABRAXANE problem was reported by a Physician from UNITED STATES on July 26, 2006. Female patient, 61 years of age, weighting 154.0 lb, was diagnosed with breast cancer metastatic and was treated with ABRAXANE. After drug was administered, patient experienced the following problems/side effects: atelectasis, dysstasia, gait disturbance, loss of proprioception, lung infiltration, neurotoxicity, pleural effusion. ABRAXANE dosage: (221 MG, EVERY 21 DAYS), INTRAVENOUS DRIP. During the same period patient was treated with XELODA, NEURONTIN, COUMADIN, LASIX, POTASSIUM, EFFEXOR, MIDODRINE HYDROCHLORIDE. Patient was hospitalized and became disabled. Patient recovered.
Abraxane Side Effects Report #5083644-6
Health Professional from UNITED STATES reported ABRAXANE problem on July 31, 2006. Female patient, 69 years of age, weighting 174.0 lb, was diagnosed with breast cancer metastatic and was treated with ABRAXANE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, anaemia, anorexia, aspartate aminotransferase increased, blood alkaline phosphatase increased, neutropenia, weight decreased. ABRAXANE dosage: unknown. During the same period patient was treated with ZOMETA, COMPAZINE, TOPROL, ASPIRIN. Patient recovered.
Abraxane Side Effects Report #5084304-8
ABRAXANE problem was reported by a Health Professional from UNITED STATES on Aug 01, 2006. Male patient, 68 years of age, weighting 198.0 lb, was diagnosed with non-small cell lung cancer and was treated with ABRAXANE. After drug was administered, patient experienced the following problems/side effects: aptyalism, constipation, decreased appetite, febrile neutropenia, haematocrit decreased, haemoglobin decreased, hypokalaemia, hypomagnesaemia, platelet count decreased. ABRAXANE dosage: 2 DOSES (600 MG) INTRAVENOUS. During the same period patient was treated with CARBOPLATIN, AVASTIN. Patient was hospitalized. Patient recovered.
Abraxane Side Effects Report #5084934-3
Physician from UNITED STATES reported ABRAXANE problem on July 28, 2006. Female patient, 53 years of age, weighting 106.5 lb, was diagnosed with breast cancer metastatic and was treated with ABRAXANE. After drug was administered, patient experienced the following problems/side effects: facial palsy. ABRAXANE dosage: 260 MG (367 MG/M2, EVERY 3 WEEKS), INTRAVENOUS DRIP. During the same period patient was treated with FOSAMAX, COMPAZINE, NEULASTA. Patient recovered.
Abraxane Side Effects Report #5085086-6
ABRAXANE problem was reported by a Health Professional from UNITED STATES on Aug 03, 2006. Female patient, 41 years of age, was diagnosed with breast cancer metastatic and was treated with ABRAXANE. After drug was administered, patient experienced the following problems/side effects: dysarthria, hypoaesthesia facial, neutropenia, sepsis. ABRAXANE dosage: 1 DOSE (260 MG/M2), INTRAVENOUS DRIP. Patient was hospitalized. Patient recovered.
Abraxane Side Effects Report #5085090-8
Physician from UNITED STATES reported ABRAXANE problem on Aug 02, 2006. Female patient, 48 years of age, weighting 118.0 lb, was diagnosed with breast cancer metastatic and was treated with ABRAXANE. After drug was administered, patient experienced the following problems/side effects: blood calcium decreased, blood creatinine decreased, blood sodium decreased, blood urea decreased, cholangitis acute, cholelithiasis, cholestasis, chronic obstructive pulmonary disease, haematocrit decreased. ABRAXANE dosage: unknown. During the same period patient was treated with AVASTIN, NEXIUM, RISPERDAL, BENADRYL, DECADRON, ZANTAC, ALOXI, OXYCONTIN. Patient recovered.
Abraxane Side Effects Report #5085092-1
ABRAXANE problem was reported by a Physician from UNITED STATES on Aug 04, 2006. Female patient, 78 years of age, was diagnosed with inflammatory carcinoma of the breast and was treated with ABRAXANE. After drug was administered, patient experienced the following problems/side effects: asthenia, impaired self-care, movement disorder, neuropathy, spinal cord compression. ABRAXANE dosage: 178 MG/ 18 DOSES (100 MG/M2, WEEKLY FOR 3 WEEKS - 1 WK OFF), INTRAVENOUS DRIP. During the same period patient was treated with PHENERGAN, EZETIMIBE, ALBUTEROL, AVASTIN, MORPHINE. Patient was hospitalized and became disabled. Patient recovered.
Abraxane Side Effects Report #5085466-9
Consumer or non-health professional from UNITED STATES reported ABRAXANE problem on Aug 03, 2006. Female patient, 41 years of age, was diagnosed with breast cancer metastatic and was treated with ABRAXANE. After drug was administered, patient experienced the following problems/side effects: dysarthria, hypoaesthesia facial, neutropenia, sepsis. ABRAXANE dosage: 1 DOSE (260 MG/M2), INTRAVENOUS DRIP. Patient was hospitalized. Patient recovered.
Abraxane Side Effects Report #5085472-4
ABRAXANE problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 03, 2006. Female patient, 62 years of age, was diagnosed with breast cancer metastatic and was treated with ABRAXANE. After drug was administered, patient experienced the following problems/side effects: alopecia, hypoaesthesia facial, nausea, neutropenia, sepsis. ABRAXANE dosage: 260 MG/M2 1 DOSE (260 MG/M2), INTRAVENOUS DRIP. Patient was hospitalized. Patient recovered.
Abraxane Side Effects Report #5085812-6
Health Professional from UNITED STATES reported ABRAXANE problem on Aug 03, 2006. Female patient, 62 years of age, weighting 179.0 lb, was diagnosed with breast cancer metastatic and was treated with ABRAXANE. After drug was administered, patient experienced the following problems/side effects: alopecia, hypoaesthesia facial, nausea, neutropenia, sepsis. ABRAXANE dosage: 260 MG/M2/1 DOSE (260 MG/M2), INTRAVENOUS DRIP. Patient was hospitalized. Patient recovered.
Abraxane Side Effects Report #5091565-8
ABRAXANE problem was reported by a Health Professional from UNITED STATES on Aug 17, 2006. Female patient, 66 years of age, weighting 163.0 lb, was diagnosed with breast cancer metastatic and was treated with ABRAXANE. After drug was administered, patient experienced the following problems/side effects: alpha haemolytic streptococcal infection, aspartate aminotransferase increased, asthenia, blood albumin decreased, blood bilirubin increased, blood glucose increased, disease progression, fatigue, liver function test abnormal. ABRAXANE dosage: 470 MG ONCE (260 MG/M2,X1), INTRAVENOUS DRIP. During the same period patient was treated with VICODIN, XELODA, EFFEXOR, SOTALOL, LEVOTHYROXINE, DIGOXIN, ACTOS, ELAVIL. Patient was hospitalized. Patient died on 03/26/2006.
Abraxane Side Effects Report #5092753-7
Physician from UNITED STATES reported ABRAXANE problem on Aug 11, 2006. Female patient, 46 years of age, weighting 120.0 lb, was diagnosed with breast cancer metastatic, depression and was treated with ABRAXANE. After drug was administered, patient experienced the following problems/side effects: cardiomegaly, cardiomyopathy, ejection fraction decreased. ABRAXANE dosage: 180MG/39 DOSES (100 MG/M2, EVERY WK X 2 WKS, OFF ONE WK, REPEAT), INTRAVENOUS DRIP. During the same period patient was treated with CYMBALTA, ZOMETA, AROMOSIN. Patient recovered.
Abraxane Side Effects Report #5096641-1
ABRAXANE problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 17, 2006. Female patient, 47 years of age, was diagnosed with breast cancer metastatic and was treated with ABRAXANE. After drug was administered, patient experienced the following problems/side effects: dehydration, neutropenia. ABRAXANE dosage: 155MG X 1 DOSE (EVERY 3 WEEKS) INTRAVENUOS DRIP. During the same period patient was treated with AVASTIN, CARBOPLATIN. Patient was hospitalized. Patient recovered.
Abraxane Side Effects Report #5096988-9
Health Professional from UNITED STATES reported ABRAXANE problem on Aug 17, 2006. Male patient, 47 years of age, weighting 112.0 lb, was diagnosed with breast cancer metastatic and was treated with ABRAXANE. After drug was administered, patient experienced the following problems/side effects: dehydration, liver function test abnormal, neutropenia. ABRAXANE dosage: 155MG X 1 DOSE (EVERY 3 WEEKS), INTRAVENOUS DRIP. During the same period patient was treated with AVASTIN, CARBOPLATIN. Patient was hospitalized. Patient recovered.
Abraxane Side Effects Report #5097127-0
ABRAXANE problem was reported by a Physician from UNITED STATES on Aug 17, 2006. Female patient, 46 years of age, weighting 182.0 lb, was diagnosed with breast cancer metastatic and was treated with ABRAXANE. After drug was administered, patient experienced the following problems/side effects: mucosal inflammation, neutropenia, oesophagitis, oral candidiasis, thrombocytopenia. ABRAXANE dosage: 507 MG DAY/1 DOSE, INTRAVENOUS DRIP. Patient was hospitalized. Patient recovered.
Abraxane Side Effects Report #5102028-5
Physician from UNITED STATES reported ABRAXANE problem on Aug 23, 2006. Female patient, 65 years of age, weighting 151.0 lb, was diagnosed with breast cancer metastatic and was treated with ABRAXANE. After drug was administered, patient experienced the following problems/side effects: activities of daily living impaired, nail bed bleeding, nail hypertrophy, nail toxicity, onychalgia, onycholysis. ABRAXANE dosage: 180 MG TOTAL DOSE (100 MG/M2,WEEKLY X 3 WEEKS THEN 1 WEEK REST). During the same period patient was treated with COUMADIN, LORTAB, KYTRIL, PHENERGAN, SYNTHROID. Patient recovered.
Abraxane Side Effects Report #5104936-8
ABRAXANE problem was reported by a Health Professional from UNITED STATES on Aug 29, 2006. Female patient, 47 years of age, weighting 112.0 lb, was diagnosed with breast cancer metastatic and was treated with ABRAXANE. After drug was administered, patient experienced the following problems/side effects: abscess limb, anaemia, blood calcium decreased, blood chloride increased, blood glucose increased, blood potassium increased, blood urea increased, dehydration, electrolyte imbalance. ABRAXANE dosage: 155MG X 1 DOSE (SCHEDULED EVERY 3 WEEKS), INTRAVENOUS DRIP. During the same period patient was treated with CARBOPLATIN, AVASTIN, NEXIUM, ADVIL, OXYCODONE. Patient was hospitalized. Patient recovered.
Abraxane Side Effects Report #5107994-X
Health Professional from UNITED STATES reported ABRAXANE problem on Sept 12, 2006. Female patient, 66 years of age, weighting 163.0 lb, was diagnosed with breast cancer metastatic and was treated with ABRAXANE. After drug was administered, patient experienced the following problems/side effects: alpha haemolytic streptococcal infection, disease progression, globulins increased, metastases to liver, mucosal inflammation, myalgia, oral candidiasis, pancytopenia, sepsis. ABRAXANE dosage: 470 MG ONCE (260 MG/M2, X 1), INTRAVENOUS DRIP. During the same period patient was treated with VICODIN, XELODA, EFFEXOR, SOTALOL, LEVOTHYROXINE, DIGOXIN, ACTOS, ELAVIL. Patient was hospitalized. Patient died on 03/26/2006.
Abraxane Side Effects Report #5108520-1
ABRAXANE problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 12, 2006. Female patient, 66 years of age, was diagnosed with breast cancer metastatic and was treated with ABRAXANE. After drug was administered, patient experienced the following problems/side effects: alpha haemolytic streptococcal infection, blood albumin decreased, blood glucose increased, disease progression, mucosal inflammation, oral candidiasis, pancytopenia, sepsis. ABRAXANE dosage: 470 MG ONCE (260 MG/M2, X 1). During the same period patient was treated with VICODIN, XELODA, VENLAFAXINE, SOTALOL, LEVOTHYROXINE, DIGOXIN, ACTOS, ELAVIL. Patient was hospitalized. Patient died.
Abraxane Side Effects Report #5117150-7
Health Professional from UNITED STATES reported ABRAXANE problem on Sept 27, 2006. Female patient, weighting 156.0 lb, was diagnosed with breast cancer stage iii and was treated with ABRAXANE. After drug was administered, patient experienced the following problems/side effects: hepatic enzyme increased, hepatic function abnormal, palmar-plantar erythrodysaesthesia syndrome, palpitations, tachycardia. ABRAXANE dosage: unknown. Patient recovered.
Abraxane Side Effects Report #5126547-0
ABRAXANE problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 11, 2006. Female patient, 45 years of age, weighting 105.0 lb, was diagnosed with disease recurrence, ovarian cancer and was treated with ABRAXANE. After drug was administered, patient experienced the following problems/side effects: dyspnoea. ABRAXANE dosage: 145.0MG/M2 D1,D8,D15 042. During the same period patient was treated with CARBOPLATIN, AMBIEN, LOVENOX, ACETAMINOPHEN, PROMETHAZINE, ATIVAN. Patient was hospitalized. Patient recovered.
Abraxane Side Effects Report #5126548-2
Consumer or non-health professional from UNITED STATES reported ABRAXANE problem on Oct 11, 2006. Female patient, 45 years of age, weighting 105.0 lb, was diagnosed with ovarian cancer, recurrent cancer and was treated with ABRAXANE. After drug was administered, patient experienced the following problems/side effects: feeding tube complication. ABRAXANE dosage: 145.0MG/M2 D1,D8,D15 042. During the same period patient was treated with CARBOPLATIN, DOXIL, ATIVAN, ZOFRAN. Patient was hospitalized. Patient recovered.
Abraxane Side Effects Report #5126907-8
ABRAXANE problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 11, 2006. Female patient, 45 years of age, weighting 105.0 lb, was diagnosed with ovarian cancer, recurrent cancer and was treated with ABRAXANE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, ascites. ABRAXANE dosage: 145.0MG/M2 D1,D8,D15 042 OVER (30MINS). During the same period patient was treated with CARBOPLATIN, SOD CL, HEPARIN, AMITRIPTYLINE, PANTOPRAZOLE. Patient was hospitalized. Patient recovered.
Abraxane Side Effects Report #5126910-8
Consumer or non-health professional from UNITED STATES reported ABRAXANE problem on Oct 11, 2006. Female patient, 45 years of age, weighting 105.0 lb, was diagnosed with ovarian cancer, recurrent cancer and was treated with ABRAXANE. After drug was administered, patient experienced the following problems/side effects: abdominal distension, dyspnoea, nausea, pyrexia, vomiting. ABRAXANE dosage: 145.0MG D1,D8,D15 042. During the same period patient was treated with CARBOPLATIN, DOXIL, AMITRIPTYLINE, LEVAQUIN. Patient was hospitalized. Patient recovered.
Abraxane Side Effects Report #5126912-1
ABRAXANE problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 11, 2006. Female patient, 45 years of age, weighting 105.0 lb, was diagnosed with ovarian cancer, recurrent cancer and was treated with ABRAXANE. After drug was administered, patient experienced the following problems/side effects: abdominal distension, chills, nausea, pain, pyrexia, vomiting. ABRAXANE dosage: 145.0MG/M2 D1,D8,D15 042 OVER 30 MINNS. During the same period patient was treated with CARBOPLATIN, DOXIL, SOD CL, HEPARIN, TRIAMTERENE. Patient was hospitalized. Patient recovered.
Abraxane Side Effects Report #5131458-0
Health Professional from UNITED STATES reported ABRAXANE problem on Oct 02, 2006. Male patient, 66 years of age, weighting 223.8 lb, was diagnosed with breast cancer metastatic, anaemia of malignant disease, hypercholesterolaemia, neutropenia and was treated with ABRAXANE. After drug was administered, patient experienced the following problems/side effects: anaemia, cardiac failure congestive, chest pain, dehydration, dyspnoea, musculoskeletal chest pain, neutropenia, palpitations, pneumonia. ABRAXANE dosage: LAST DOSE PRIOR TO FIRST EVENT 28-APR-2006 (175 MG/M2, EVERY 3 WEEKS), INTRAVENOUS DRIP. During the same period patient was treated with PROCRIT, CYTOXAN, DOXORUBICIN, ASPIRIN, NEUPOGEN, LIPITOR, LORTAB. Patient was hospitalized. Patient recovered.
Abraxane Side Effects Report #5132281-3
ABRAXANE problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 11, 2006. Female patient, 45 years of age, weighting 105.0 lb, was diagnosed with neoplasm recurrence, ovarian cancer and was treated with ABRAXANE. After drug was administered, patient experienced the following problems/side effects: constipation, nausea, pain, vomiting. ABRAXANE dosage: 145.0MG/M2 D1,D8,D15 042 OVER 30 MINS. During the same period patient was treated with CARBOPLATIN, DOXIL, ATIVAN, HYDROMORPHONE, ZOFRAN. Patient was hospitalized. Patient recovered.
Abraxane Side Effects Report #5132282-5
Consumer or non-health professional from UNITED STATES reported ABRAXANE problem on Oct 11, 2006. Female patient, 45 years of age, weighting 105.0 lb, was diagnosed with neoplasm recurrence, ovarian cancer and was treated with ABRAXANE. After drug was administered, patient experienced the following problems/side effects: nausea, pyrexia, stomach discomfort, vomiting. ABRAXANE dosage: 145.0MG/M2 D1,D8,D15 042 OVER 30 MINS. During the same period patient was treated with CARBOPLATIN, DOXIL, FENTANYL TRANSDERMAL SYSTEM, AMITRIPTYLINE, ESTRADIOL. Patient was hospitalized. Patient recovered.
Abraxane Side Effects Report #5135641-X
ABRAXANE problem was reported by a Health Professional from UNITED STATES on Oct 10, 2006. Male patient, 66 years of age, weighting 223.8 lb, was diagnosed with breast cancer metastatic, anaemia of malignant disease, hypercholesterolaemia, neutropenia and was treated with ABRAXANE. After drug was administered, patient experienced the following problems/side effects: anaemia of malignant disease, arrhythmia supraventricular, bone pain, cardiac failure congestive, dehydration, febrile neutropenia, fluid overload, gallbladder polyp, gastrooesophageal reflux disease. ABRAXANE dosage: LAST DOSE PRIOT TO FIRST EVENT 28-APR 2006 (175 MG/M2, EVERY 3 WEEKS), INTRAVENOUS DRIP. During the same period patient was treated with PROCRIT, CYTOXAN, DOXORUBICIN, ASPIRIN, NEUPOGEN, LIPITOR, LORTAB. Patient was hospitalized. Patient recovered.
Abraxane Side Effects Report #5147392-6
Physician from UNITED STATES reported ABRAXANE problem on Oct 23, 2006. Female patient, 55 years of age, weighting 152.1 lb, was diagnosed with breast cancer stage iv and was treated with ABRAXANE. After drug was administered, patient experienced the following problems/side effects: facial palsy, lip disorder, muscular weakness, neuropathy. ABRAXANE dosage: 14 CYCLES COMPLETED (260 MG/M2, EVERY 3-WKS), INTRAVENOUS. During the same period patient was treated with VITAMIN A. Patient recovered.
Abraxane Side Effects Report #5147955-8
ABRAXANE problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 23, 2006. Female patient, 55 years of age, was diagnosed with breast cancer stage iv and was treated with ABRAXANE. After drug was administered, patient experienced the following problems/side effects: asthenia, eyelid function disorder, facial palsy, neuropathy. ABRAXANE dosage: 14 CYCLES COMPLETED (260 MG/M2, EVERY 3-WKS); INTRAVENOUS. During the same period patient was treated with VITAMIN A. Patient recovered.
Abraxane Side Effects Report #5157570-8
Physician from UNITED STATES reported ABRAXANE problem on Sept 11, 2006. Female patient, 61 years of age, weighting 218.0 lb, was diagnosed with breast cancer metastatic and was treated with ABRAXANE. After drug was administered, patient experienced the following problems/side effects: abscess, cellulitis, disease recurrence, mastitis, skin necrosis. ABRAXANE dosage: 250 MG/M2 (DOSING ON DAYS 1, 8 Q 21 DAYS), INTRAVENOUS. During the same period patient was treated with XELODA, CELEBREX, NEUPOGEN. Patient was hospitalized. Patient recovered.
Abraxane Side Effects Report #5157600-3
ABRAXANE problem was reported by a Physician from UNITED STATES on Nov 02, 2006. Female patient, 66 years of age, weighting 207.0 lb, was diagnosed with breast cancer metastatic and was treated with ABRAXANE. After drug was administered, patient experienced the following problems/side effects: bacterial infection, neutropenic sepsis, respiratory failure. ABRAXANE dosage: RECEIVED ONE DOSE/ 520 MG (260 MG/M2), INTRAVENOUS. During the same period patient was treated with AVANDIA, AMARYL, COREG, PROCARDIA, METFORMIN, XALATAN, COLACE. Patient was hospitalized. Patient died on 10/19/2006.
Abraxane Side Effects Report #5162557-5
Health Professional from UNITED STATES reported ABRAXANE problem on Nov 07, 2006. Female patient, 43 years of age, weighting 218.0 lb, was diagnosed with breast cancer, anaemia of malignant disease and was treated with ABRAXANE. After drug was administered, patient experienced the following problems/side effects: asthma, bronchitis, condition aggravated. ABRAXANE dosage: (175 MG/M2, ONCE EVERY THREE WEEKS), INTRAVENOUS. During the same period patient was treated with CYTOXAN, ADRIAMYCIN PFS, PROCRIT. Patient was hospitalized. Patient recovered.
Abraxane Side Effects Report #5194090-9
ABRAXANE problem was reported by a Physician from UNITED STATES on Dec 08, 2006. Female patient, 66 years of age, weighting 207.0 lb, was diagnosed with breast cancer metastatic and was treated with ABRAXANE. After drug was administered, patient experienced the following problems/side effects: bacterial infection, blood culture positive, febrile neutropenia, malaise, neutropenic sepsis, respiratory failure. ABRAXANE dosage: RECEIVED ONE DOSE/520 MG (260 MG/M2), INTRAVENOUS. During the same period patient was treated with AVANDIA, AMARYL, COREG, PROCARDIA, METORMIN, XALATAN, COLACE. Patient was hospitalized. Patient died on 10/19/2006.
Abraxane Side Effects Report #5198375-1
Health Professional from UNITED STATES reported ABRAXANE problem on Dec 28, 2006. Female patient, weighting 166.2 lb, was diagnosed with breast cancer metastatic and was treated with ABRAXANE. After drug was administered, patient experienced the following problems/side effects: application site erythema, application site exfoliation, application site pain, application site vesicles, condition aggravated, palmar-plantar erythrodysaesthesia syndrome. ABRAXANE dosage: 100 MG/ML WEEKLY IV DRIP. Patient recovered.
Abraxane Side Effects Report #5391227-3
ABRAXANE problem was reported by a Physician from UNITED STATES on July 02, 2007. Female patient, 53 years of age, weighting 137.0 lb, was diagnosed with breast cancer, colony stimulating factor prophylaxis and was treated with ABRAXANE. After drug was administered, patient experienced the following problems/side effects: abscess intestinal, candidiasis, clostridium difficile toxin test positive, diverticulitis, enterocolitis infectious, escherichia infection, haemoglobin increased, lung consolidation, platelet count decreased. ABRAXANE dosage: unknown. During the same period patient was treated with GEMCITABINE, EPIRUBICIN, NEULASTA, EMEND, COMPAZINE, DARVOCET, MIRALAX, DICYCLOMINE. Patient was hospitalized. Patient recovered.
Abraxane Side Effects Report #5397671-2
Pharmacist from UNITED STATES reported ABRAXANE problem on July 23, 2007. Female patient, weighting 251.0 lb, was diagnosed with breast cancer metastatic, anaemia and was treated with ABRAXANE. After drug was administered, patient experienced the following problems/side effects: adverse event, feeling of body temperature change, nail disorder, neuropathy peripheral, sensitivity of teeth. ABRAXANE dosage: 220 MG 3 WKS ON, 1 WK OFF IV. During the same period patient was treated with ARANESP. Patient recovered.
Abraxane Side Effects Report #5398599-4
ABRAXANE problem was reported by a Physician from UNITED STATES on July 18, 2007. Female patient, 56 years of age, weighting 143.3 lb, was diagnosed with breast cancer metastatic and was treated with ABRAXANE. After drug was administered, patient experienced the following problems/side effects: abdominal distension, hepatic vein thrombosis, metastases to liver. ABRAXANE dosage: unknown. During the same period patient was treated with ARIMIDEX, GEMZAR. Patient died.
Abraxane Side Effects Report #5404082-X
Physician from UNITED STATES reported ABRAXANE problem on July 18, 2007. Female patient, 68 years of age, was diagnosed with breast cancer metastatic and was treated with ABRAXANE. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, oedema, pleural effusion. ABRAXANE dosage: (100 MG/M2, WEEKLY). During the same period patient was treated with CAMPTOSAR. Patient was hospitalized. Patient recovered.
Abraxane Side Effects Report #5405951-7
ABRAXANE problem was reported by a Physician from UNITED STATES on July 18, 2007. Female patient, 41 years of age, was diagnosed with breast cancer and was treated with ABRAXANE. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, chest pain, condition aggravated, hypothyroidism, myopathy, pain in extremity, thyroiditis. ABRAXANE dosage: unknown. During the same period patient was treated with AVASTIN, CYTOXAN, ADRIAMYCIN, NEULASTA, APREPITANT, BISOPROLOL FUMARATE, DEXAMETHASONE, DOCUSATE. Patient was hospitalized. Patient recovered.
Abraxane Side Effects Report #5407897-7
Physician from UNITED STATES reported ABRAXANE problem on July 26, 2007. Female patient, 49 years of age, was diagnosed with breast cancer metastatic and was treated with ABRAXANE. After drug was administered, patient experienced the following problems/side effects: mucosal inflammation, neutropenia, palmar-plantar erythrodysaesthesia syndrome, recall phenomenon, white blood cell count decreased. ABRAXANE dosage: 225 MG/M2 INTRAVENOUS. During the same period patient was treated with NEULASTA, ZOMETA, ALTACE, DOXIL, GEMZAAR. Patient was hospitalized. Patient recovered.
Abraxane Side Effects Report #5424573-5
ABRAXANE problem was reported by a Physician from UNITED STATES on Aug 14, 2007. Female patient, 64 years of age, weighting 151.0 lb, was diagnosed with breast cancer metastatic and was treated with ABRAXANE. After drug was administered, patient experienced the following problems/side effects: haemorrhage, nail disorder, nail toxicity, onychalgia, purulence. ABRAXANE dosage: 180 MG TOTAL DOSE (100 MG/M2,WEEKLY X 3 WEEKS THEN 1 WEEK REST). During the same period patient was treated with COUMADIN, LORTAB, KYTRIL, PHENERGAN, SYNTHROID. Patient recovered.
Abraxane Side Effects Report #5424574-7
Physician from UNITED STATES reported ABRAXANE problem on Aug 08, 2007. Female patient, 63 years of age, weighting 343.9 lb, was diagnosed with breast cancer metastatic and was treated with ABRAXANE. After drug was administered, patient experienced the following problems/side effects: biopsy skin abnormal, pain, pemphigoid. ABRAXANE dosage: unknown. During the same period patient was treated with AREDIA. Patient recovered.
Abraxane Side Effects Report #5442483-4
ABRAXANE problem was reported by a Physician from UNITED STATES on Aug 21, 2007. Female patient, 56 years of age, weighting 143.3 lb, was diagnosed with breast cancer metastatic and was treated with ABRAXANE. After drug was administered, patient experienced the following problems/side effects: ascites, breath sounds abnormal, hepatic vein thrombosis, hepatosplenomegaly, international normalised ratio increased, malignant neoplasm progression, metastases to liver, oedema peripheral, pleural effusion. ABRAXANE dosage: unknown. During the same period patient was treated with ARIMIDEX, GEMZAR, ADRIAMYCIN PFS. Patient died.
Abraxane Side Effects Report #5442484-6
Physician from UNITED STATES reported ABRAXANE problem on Aug 23, 2007. Female patient, 63 years of age, weighting 343.9 lb, was diagnosed with breast cancer metastatic and was treated with ABRAXANE. After drug was administered, patient experienced the following problems/side effects: blister, pain, pemphigoid, pruritus. ABRAXANE dosage: 180 MG/DATE OF LAST DOSE 18JUL07 / 3 DOSES MG/M2, WEEKLY ( 3 WEEKS ON AND 1 WEEK OFF)), INTRAVENOUS. During the same period patient was treated with AREDIA. Patient recovered.
Abraxane Side Effects Report #5466548-6
ABRAXANE problem was reported by a Health Professional from UNITED STATES on Aug 29, 2007. Female patient, 45 years of age, weighting 148.0 lb, was diagnosed with breast cancer and was treated with ABRAXANE. After drug was administered, patient experienced the following problems/side effects: rash pruritic. ABRAXANE dosage: 260MG.M2/Q 21 DAYS/IV. During the same period patient was treated with XELODA, ABILIFY, TYLENOL W. Patient recovered.
Abraxane Side Effects Report #5450878-8
Pharmacist from UNITED STATES reported ABRAXANE problem on Aug 27, 2007. Female patient was diagnosed with breast cancer metastatic and was treated with ABRAXANE. After drug was administered, patient experienced the following problems/side effects: hepatic failure. ABRAXANE dosage: 125 MG/M2. Patient died.
Abraxane Side Effects Report #5452265-5
ABRAXANE problem was reported by a Pharmacist from UNITED STATES on Sept 12, 2007. Female patient, 59 years of age, weighting 198.4 lb, was diagnosed with breast cancer metastatic and was treated with ABRAXANE. After drug was administered, patient experienced the following problems/side effects: asthenia, dysuria, heart rate increased, hepatic failure, mental status changes, oedema peripheral, oesophageal varices haemorrhage, pain in extremity, rash. ABRAXANE dosage: 244 MG -125 MG/M2- WEEKLY IV. Patient died on 08/24/2007.
Showing 1-50 of 101 Next >